
AI for Biology PhD Student @GriffinCMU | Advised by @jmuiuc and @ericxing | 🪀
Joined June 2021
- Tweets142
- Following775
- Followers234
- Likes1.5K
Nicholas Ho retweeted
Cell-state conditioned sequence model of chromatin & expression trained jointly across diverse cell contexts by @zhou_jingtian & colleagues. Nice addition to the growing collection of joint cis-trans models of gene regulation. Still lots to do make the trans component causal.
Our cells carry the same DNA, but how this DNA is interpreted differs wildly from cell to cell. In a new preprint, Science Fellow @zhou_jingtian and team introduce Bolero, a model conditioned on cell state that predicts chromatin accessibility and expression from DNA alone.
Nicholas Ho retweeted
In our Nature paper, we introduce the first superhuman Stratego AI, which we built using general techniques that we developed for RL & test-time compute under imperfect information. 1/N
We asked a basic unanswered question in tissue biology: Can the many molecular exchanges between neighboring cells be organized into reusable communication programs - much like genes into pathways?
We introduce SpiderNet, which learns cell-cell meta-interactions (MIs): directed sender->receiver programs linking sender regulators, ligand-receptor bridges, and receiver responses, while mapping where each program is active in tissue. Across diverse contexts, MIs recur, form multicellular relays, predict neighboring-cell responses to perturbation, and connect local signaling to tissue states and phenotypes.
We hope MIs provide an intermediate language for spatial omics, moving from catalogs of local contacts toward interpretable, comparable, and eventually perturbable programs of multicellular regulation.
📚 Preprint: biorxiv.org/content/10.64898…
🚀 Led by the amazing Junjie Tang @JJTang_1995 in the lab.
I spoke with @Nature, alongside several other researchers, about why many AI researchers still choose academia despite the growing pull of industry. Academia's unusual freedom to choose which questions are worth pursuing is powerful. But I do not think academia and industry need to be opposites. As AI reshapes science, we need models that let them co-evolve, combining academia's long-term freedom and openness with industry's resources, scale, and ability to rapidly translate ideas into impact. nature.com/articles/d41586-0…
Nicholas Ho retweeted
Do spatial transcriptomics foundation models (SFMs) actually learn biologically meaningful spatial patterns? 🧬
Excited to share our new work assessing if current spatial foundation models learn multi-scale spatial variation in gene expression (spoiler: mostly no)
20 years ago today, on April 7, 2006, I submitted the only paper I published during my PhD to @genomeresearch. By today's standards, the work feels too simple, and every figure looks plain. Science has moved fast, and I am working on completely different problems now. That era is gone. genome.cshlp.org/content/16/…
very comprehensive Review on single-cell foundation models from @JiayuanDing, @Xiaojie_Qiu, @TheodorisLab, and colleagues. After going over it, I would encourage the authors to make it more critical rather than primarily an inventory of models.
First, I think Fig 1 needs some rethinking. The definition of scFM has become too loose. For example, the actual model unit of GET is celltype pseudobulk aggregated from scATAC-seq, hence not single cell model. Also thanks for highlighting our TissueNarrator, but we certainly do not consider it a bona fide scFM - it is a specialized spatial transcriptomics model built by leverging an existing foundation LLM (Qwen). TissueNarrator is very interesting and we re having lots of fun w/ it but it's not a scFM. Anyway - Fig 1 seems to mix FMs, specialized models built on FMs, and task-specific models into one big family tree.
More broadly, I think the more interesting question for a scFM review in 2026 is not how many scFMs now exist or how their architectures differ, but what has the scFM paradigm actually bought us? Since the first wave around scBERT/Geneformer/scGPT, the number of models, parameters, and pretraining cells has exploded, but as a field we are not convinced that capabilities have advanced proportionally.
- Where has large scale pretraining enabled something that a strong specialized model could not do ?
- Where do scFMs consistently beat strong task specific or even simple baselines?
- Where is the broad evidence for true cross-context generalization on biologically interesting tasks?
The Review mentions many of these challenges indeed, but I think they should be much closer to the central theme of the article rather than appearing mainly in a later Challenges section :-)
I might almost suggest to flip the review around and instead ask:
- what have we actually learned after several years and many scFMs?
- What claims have survived independent benchmarking?
- What has scaled and what has saturated?
- What capabilities are genuinely attributable to pretraining and where do we still need much more evidnece?
- What important biological problems remain essentially unsolved by scFMs ?
Given the current rate of model proliferation, there may be another 50 scFMs by this time next year and this inventory / figure will become outdated very quickly. To me, a more useful and timely "state of the field" critique would be much more valuable and long-lasting than another "model zoo" review .
Are single-cell foundation models (scFMs) a true biological breakthrough, or just over-hyped architecture tweaks?
To separate genuine conceptual advances from incremental hype, the lead authors of pioneer models, including Geneformer, Cell2sentence @david_van_dijk , Nicheformer @fabian_theis , GET @raulrabadan, CellPLM @tangjiliang , and our Tabula, have united to publish a systematic, critical synthesis of the scFM landscape.
Designed for the broader scientific community, this guide cuts through the noise to show how emerging model designs can truly support grounded biological discovery.
📄 Paper: lnkd.in/gSxJBEwt
📷 Curated paper list: lnkd.in/gU4R4Rt3
Led by the incredible @JiayuanDing
and @shiyu_jiang23 , Zhaoyu Fang, Yujie Zhang, @xutzhang , @jkobject , Weixu Wang, @alexanderfuxi , Aakash Patel, Syed Rizvi, @Y_Ryan_Lu , @SiyuHe7 , @YixinxinWang , @KejunYing , @peterpaohuang , @YifanLu2024 , @Nanguage , Mengchen Wang, Ziyang Miao, Jianhui Lin, Jimmy Ding, Jerry Wang, @imweio , @TianlongChen4 , Guoxian Yu, Min Li, Jiayi Ma, @feiwang03 , @Yuyingxie , @cmuptx , @PengHeAtlas , Emily B. Fox, @dasongle , @ericxing
Give it a read, we hope you will enjoy it!
As a collaboration between my group at @SCSatCMU, Aviv Regev's team at @genentech, and @michellearning's team at @medra_ai, we are pleased to share our Perspective, "Towards human-led, agent-driven autonomous laboratories for the life sciences." 🤖 preprints.org/manuscript/202…
This preprint release is coordinated with a complementary Perspective by @MengdiWang10, @lecong, and colleagues: preprints.org/manuscript/202…. Together, the two Perspectives examine the future of autonomous science from complementary angles.
Our Perspective was Led by @WenduoC in my group, with @mishamamq, @ShenShuaik4260 and @zocean636 at CMU; Anna Hupalowska, Jennifer Rood, Christine Bakan, and Aviv Regev at @genentech/@Roche; and Gaurav Agrawal and @michellearning at @medra_ai.
🚀preprints.org/manuscript/202…
Replying to @BoWang87
Well, drugs are just one application. Biology is much broader. If these VC models truly live up to their promise, they should indeed help us understand, predict / simulate, and design biological systems. I believe that has always been the larger vision of computational biology ?
Nicholas Ho retweeted
Excited to showcase the science and people behind our GigaTIME paper, recently published in Cell.
Paper: aka.ms/gigatime-paper
Model: aka.ms/gigatime-model
Code: aka.ms/gigatime-code
Azure Foundry: labs.ai.azure.com/projects/g…
Nicholas Ho retweeted
Thrilled to announce alphagenome-pytorch, an accurate, readable, and careful port of AlphaGenome's architecture and weights to PyTorch. Work with @gtcaa @m_kjellberg @chriswzou @tuxinming as part of the GenomicsxAI initiative between @anshulkundaje and @pkoo562 labs.
Nicholas Ho retweeted
Excited to share our new work. Over the past decade, single-cell genomics has transformed our ability to map cellular systems. But a major question remains:
Can we predict how perturbations reshape cellular trajectories over time?
In 2018, we first showed that it is possible to predict cellular responses to perturbations — ranging from disease signals to chemical treatments — even in unseen contexts. In 2022, we introduced CPA (MSB 2022; NeurIPS 2022), extending this idea to predict responses to unseen chemical and genetic perturbations, including their combinations.
Since then, the field of perturbation modeling has grown enormously. The community has pushed the space forward with many creative ideas and powerful models. It’s exciting to see how fast things are moving — even though many fundamental challenges remain.
One of the biggest is that cells are not static. They move through trajectories during development, immune responses, and disease. Yet most current models still predict perturbation effects within a single state, rather than how early perturbations propagate across future states and reshape downstream outcomes.
To address this, we developed PerturbGen, a trajectory-aware generative AI model that predicts how genetic perturbations reshape downstream cellular states.
Huge credit to the people who made this work possible. Thanks to co-first authors @lifeisscience_5, @Adib_m_, @Tomo_Isobe, @Amirhossein Vahidi, @delshadveghari & Anthony Rostron. Special recognition to @lifeisscience_5 and @Adib_m_ for driving this work over the finish line.
Grateful for our outstanding collaborators from @HaniffaLab, @BertieGottgens lab @GosiaTrynka and many others — a true cross-institute effort across @SCICambridge, @OpenTargets ,@sangerinstitute and @Cambridge_Uni.🎉
PerturbGen learns transcriptional dynamics across cellular trajectories. By introducing perturbations at an early source state, it can simulate how these effects propagate into future states along differentiation trajectories.
Scaling this across genes enables the creation of dynamic in silico perturbation atlases — maps of how perturbations reshape biological trajectories over time.
We explored this idea across three biological questions.
First, in a human in vivo LPS immune challenge, PerturbGen predicted that perturbing a transient IL1B signal dampens downstream inflammatory programs in myeloid cells, with pathway changes reversing signatures observed in an independent IL-1β stimulation experiment.
Second, in human hematopoiesis, PerturbGen predicted transcriptional responses to CRISPR transcription factor knockouts and enabled construction of perturbation atlases revealing lineage- and age-specific regulatory programs. These programs could also be linked to human genetics and blood diseases, including recapitulation of signatures associated with ETV6-related thrombocytopenia.
Finally, we asked whether perturbation modeling could help improve complex tissue models.
We built a dynamic perturbation atlas of human skin organoids to identify perturbations that could guideorganoid cells towardhuman fetal skin states.
PerturbGen prioritized activation of Wnt signaling via GSK3β inhibition. Experimental validation confirmed the prediction: treatment with CHIR99021 induced stromal gene programs and shifted organoid fibroblasts toward transcriptional states observed in fetal skin stroma.
Together, these results show how trajectory-aware perturbation modeling can connect gene perturbations to developmental programs, human genetics, disease mechanisms, and experimental interventions.
More broadly, we think these point toward a future where single-cell atlases become predictive systems.
As atlases expand across tissues, developmental windows, and modalities, models like PerturbGen could enable dynamic, virtual perturbation atlases— allowing us to simulate interventions, generate hypotheses, and design experiments before stepping into the lab.
Preprint
shorturl.at/EkisP
Code
github.com/Lotfollahi-lab/Pe…
Excited to see how the community builds on this work.
Nicholas Ho retweeted
AlphaGenome is out in @nature today along with model weights! 🧬
📄 Paper: nature.com/articles/s41586-0…
💻 Weights: github.com/google-deepmind/a…
Getting here wasn’t a straight path. We sat down @googledeepmind to discuss the story behind the model, paper & API: youtu.be/V8lhUqKqzUc
Honored and grateful to be named an ACM Fellow. cs.cmu.edu/news/2026/ma-acm-…
Nicholas Ho retweeted
Super excited to see that @genbioai was highlighted in Dr. @LisaSu's keynote talk.
Thank you so much, @AMD — we look forward to what we will achieve together in 2026!
Chair and Chief Executive Officer at AMD, Dr. @LisaSu, highlighted our partnership during her CES 2026 keynote.
At #CES2026 in Las Vegas, GenBio AI joined @AMD to share a vision for advancing biology with AI.
Together, we are building the foundation for personalized treatments made just for you.
Learn more and stay tuned → x.genbio.ai/amd-genbio-ces-2…
Nicholas Ho retweeted
Together with Emma Dann, we are thrilled to present a massive new Perturb-seq atlas of 22M primary CD4+ T cells, from 4 donors, across 3 timepoints – the result of a decade-long collaboration between the Marson (@MarsonLab) and Pritchard (@jkpritch) labs.
🧵👇
Nicholas Ho retweeted
MBZUAI’s Institute of Foundation Models has released K2-V2, a 70B reasoning model that is tied for #1 in our Openness Index, and is the first model on our leaderboards from the UAE
📖 Tied leader in Openness: K2-V2 joins OLMo 3 32B Think at the top of the Artificial Analysis Openness Index - our newly released, standardized, independently assessed measure of AI model openness across availability and transparency. MBZUAI went beyond open access and licensing of the model weights - they provide full access to pre- and post-training data. They also publish training methodology and code with a permissive Apache license allowing free use for any purpose. This makes K2-V2 a valuable contribution to the open source community and allows more effective fine-tuning. See links below!
🧠 Strong medium-sized (40-150B) open weights model: At 70B, K2-V2 scores 46 on our Intelligence Index with its High reasoning mode. This puts it above Llama Nemotron Super 49B v1.5 but below Qwen3 Next 80B A3B. The model has a relative strength in instruction following with a score of 60% in IFBench
🇦🇪 First UAE entrant on our leaderboards: In a sea of largely US and Chinese models, K2-V2 stands out as the first representation of the UAE in our leaderboards, and the second entrant from the Middle East after Israel’s AI21 labs. K2-V2 is the first MBZUAI model we have benchmarked, but the lab has previously released models with a particular focus on language representation including Egyptian Arabic and Hindi
📊 Lower reasoning modes reduce token use & hallucination: K2-V2 has 3 reasoning modes, with the High reasoning mode using a substantial ~130M tokens to complete our Intelligence Index. However, the Medium mode reduces token usage by ~6x with only a 6pt drop in our Intelligence Index. Interestingly, lower reasoning modes score better in our knowledge and hallucination index, AA-Omniscience, due to a reduced tendency to hallucinate
Nicholas Ho retweeted
Have you heard about the Night Science Podcast, where we talk about the creative process of doing science? We explore this with discussions with brilliant scientists & philosophers and artists, to figure out the tricks of the creative scientific trade.
podcasts.apple.com/us/podcas…
Nicholas Ho retweeted
I am excited to serve as Proceedings Chair with @kmborgwardt for #ISMB2026 in Washington DC. We have brought together a strong and diverse group of Area Chairs. It is a truly exciting and exhilarating time for #CompBio. Look forward to your paper submissions by the 1/20 deadline
📢 Submit to #ISMB2026 Proceedings!
Share your latest research in #computationalbiology and #bioinformatics. Accepted papers will be published in a special open-access issue of Bioinformatics.
🗓️ Submission deadline: January 20, 2026
🔗 Learn more: iscb.org/ismb2026/call-for-s…
Nicholas Ho retweeted
#LLOKI, for cross-platform integration of spatial transcriptomics, is now published in @genomeresearch! 🎉 Work led by @ellie_haber (@mldcmu) and Lane Fellow @SpencerKrieger (@CMUCompBio). Earlier version in #RECOMB2025. LLOKI is pronounced "low-key". genome.cshlp.org/content/ear…
Integrating spatial transcriptomics across platforms is hard - different gene panels, sparse data. We introduce LLOKI, using optimal transport + single-cell FMs for unified ST integration. Work led by @ellie_haber (@mldcmu) & Lane Fellow @SpencerKrieger biorxiv.org/content/10.1101/…





























